Awareness of Being Prescribed Antihypertensive Medications and Cardiovascular Outcomes-Reference-Cited by-同舟云学术

Awareness of Being Prescribed Antihypertensive Medications and Cardiovascular Outcomes

Published:2024-04-04 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Suzuki Yuta¹²,Kaneko Hidehiro¹³,Okada Akira⁴,Komuro Jin¹⁵,Mizuno Atsushi¹⁶⁷,Fujiu Katsuhito¹³,Jo Taisuke⁸,Takeda Norifumi¹,Morita Hiroyuki¹,Nishiyama Akira⁹,Yano Yuichiro¹⁰¹¹,Node Koichi¹²,Yasunaga Hideo¹³,Komuro Issei¹¹⁴¹⁵

Affiliation:

1. Department of Cardiovascular Medicine, The University of Tokyo

2. Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health

3. Department of Advanced Cardiology, The University of Tokyo

4. Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo

5. Department of Cardiology, Keio University School of Medicine

6. Department of Cardiovascular Medicine, St. Luke’s International Hospital

7. Leonard Davis Institute for Health Economics, University of Pennsylvania

8. Department of Health Services Research, The University of Tokyo

9. Department of Pharmacology, Faculty of Medicine, Kagawa University

10. Department of General Medicine, Juntendo University Faculty of Medicine

11. Department of Family Medicine and Community Health, Duke University

12. Department of Cardiovascular Medicine, Saga University

13. Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo

14. Department of Frontier Cardiovascular Science, Graduate School of Medicine, The University of Tokyo

15. International University of Health and Welfare

Publisher

Japanese Circulation Society

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-24-0039/_pdf

Reference24 articles.

1. 1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224–2260.

2. 2. Fenech G, Vallée A, Cherfan M, Kab S, Goldberg M, Zins M, et al. Poor awareness of hypertension in France: The CONSTANCES population-based study. Am J Hypertens 2020; 33: 543–551.

3. 3. Man REK, Gan AHW, Fenwick EK, Gan ATL, Gupta P, Sabanayagam C, et al. Prevalence, determinants and association of unawareness of diabetes, hypertension and hypercholesterolemia with poor disease control in a multi-ethnic Asian population without cardiovascular disease. Popul Health Metr 2019; 17: 17.

4. 4. Liew SJ, Lee JT, Tan CS, Koh CHG, Van Dam R, Müller-Riemenschneider F. Sociodemographic factors in relation to hypertension prevalence, awareness, treatment and control in a multi-ethnic Asian population: A cross-sectional study. BMJ Open 2019; 9: e025869.

5. 5. Owolabi EO, Goon DT, Adeniyi OV, Seekoe E. Social epidemiology of hypertension in Buffalo City Metropolitan Municipality (BCMM): Cross-sectional study of determinants of prevalence, awareness, treatment and control among South African adults. BMJ Open 2017; 7: e014349.